2012

1. Ganetespib (STA-9090), a nongeldanamycin HSP90 inhibitor, has potent antitumor activity in in vitro and in vivo models of non-small cell lung cancer

   Clinical Cancer Research, Vol. 18, Núm. 18, pp. 4973-4985